Expenditure worldwide on diabetes by market 2013-2018
This statistic shows the global spending on diabetes in developed and so called pharmerging markets from 2013 to 2018. In 2013, the developed diabetes market expended 35 billion U.S. dollars. Among others, growth in spending is driven by the increasing price of modern insulin in the United States. In developed markets, new therapies targeting diabetes is a significant driver of market growth.